Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Currie

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Nutrients|December 31, 2025
Leader-Inspired Nutrition: A Framework for Promoting Healthy Nutrition Behaviors and a Nutritionally Fueled and Fit Military ForceTanisha L Currie, Cindy Crawford, Patricia A Deuster, et al.
Veterinary Evidence|April 20, 2026
Systematic reviews of animal studies - Report of an international symposiumErik Fausak, Melissa C Funaro, Andrea C Kespel, et al.
European Urology|June 1, 2022
Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02Arlene O Siefker-Radtke, Daniel C Cho, Adi Diab, et al.
Circulation Research|February 19, 2016
Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical StudiesPeter Paul Zwetsloot, Anna Maria Dorothea Végh, Sanne Johanna Jansen of Lorkeers, et al.
Plos Biology|November 12, 2015
Correction: Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
Journal for Immunotherapy of Cancer|April 21, 2022
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 studyNizar M Tannir, Daniel C Cho, Adi Diab, et al.
Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.
Plos Biology|May 21, 2019
Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysisGillian L Currie, Helena N Angel-Scott, Lesley Colvin, et al.
Plos Biology|October 14, 2015
Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
JAMA Oncology|May 13, 2022
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain Metastases: Final Results From the Phase 3 ATTAIN Randomized Clinical TrialDebu Tripathy, Sara M Tolaney, Andrew D Seidman, et al.
Nutrients|December 31, 2025
Leader-Inspired Nutrition: A Framework for Promoting Healthy Nutrition Behaviors and a Nutritionally Fueled and Fit Military ForceTanisha L Currie, Cindy Crawford, Patricia A Deuster, et al.
Veterinary Evidence|April 20, 2026
Systematic reviews of animal studies - Report of an international symposiumErik Fausak, Melissa C Funaro, Andrea C Kespel, et al.
European Urology|June 1, 2022
Bempegaldesleukin plus Nivolumab in First-line Metastatic Urothelial Carcinoma: Results from PIVOT-02Arlene O Siefker-Radtke, Daniel C Cho, Adi Diab, et al.
Circulation Research|February 19, 2016
Cardiac Stem Cell Treatment in Myocardial Infarction: A Systematic Review and Meta-Analysis of Preclinical StudiesPeter Paul Zwetsloot, Anna Maria Dorothea Végh, Sanne Johanna Jansen of Lorkeers, et al.
Plos Biology|November 12, 2015
Correction: Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
Journal for Immunotherapy of Cancer|April 21, 2022
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 studyNizar M Tannir, Daniel C Cho, Adi Diab, et al.
Future Oncology (London, England)|January 25, 2022
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrenceAlexander Mm Eggermont, Paolo A Ascierto, Nikhil I Khushalani, et al.
Plos Biology|May 21, 2019
Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysisGillian L Currie, Helena N Angel-Scott, Lesley Colvin, et al.
Plos Biology|October 14, 2015
Risk of Bias in Reports of In Vivo Research: A Focus for ImprovementMalcolm R Macleod, Aaron Lawson McLean, Aikaterini Kyriakopoulou, et al.
Pageof 27